1. Generics Bulletin
  2. >>Leadership

Sandoz Head Francis To Leave Amid Move Towards Autonomy

 
• By Aidan Fry

Sandoz’ drive to greater efficiency and stronger profit margins through a group-wide transformation process has prompted the division’s global head, Richard Francis, to step down.

Francis_Richard
Sandoz' global head, Richard Francis, is stepping down as Novartis' generics and biosimilars division embarks on a wide-ranging transformation plan • Source: Novartis

Richard Francis, global chief executive officer of Sandoz, will step down from the position at the end of this month. He will be replaced on an ad-interim basis by Sandoz’ regional head for Europe, Francesco Balestrieri, who will report directly to parent group Novartis’ CEO, Vas Narasimhan.

Explaining his decision to resign, Francis stated: “As we announced earlier this year, Sandoz is embarking on a significant transformation

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Generics Bulletin for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Leadership

More from Generics Bulletin